Could cause temporary or reversible harm; serious harm is unlikely.
Out of specification for assay
| Brand name | AMPHOTERICIN B |
| Generic name | AMPHOTERICIN B |
| Active ingredient(s) | AMPHOTERICIN B |
| Distributed by / for | Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 |
| NDC | 62756-233-01 |
| Full product label | Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti Halol-389350, Gujarat, India. NDC 62756-233-01 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | Nationwide within the United States |
| Quantity | 11,016 vials |
| Recall initiated | 2024-04-19 |
| Report date | 2024-05-15 |
| Recall completed | — |
| Recall number | D-0493-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗